Skip to content

The impact of nutritional status on adverse clinical outcomes in patients with inflammatory bowel disease

The impact of nutritional status on adverse clinical outcomes in patients with inflammatory bowel disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104593
Enrollment
Unknown
Registered
2025-06-19
Start date
2025-06-20
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease

Interventions

Patients with inflammatory bowel disease:None

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.The patient's age was >=14 years old; 2.Diagnostic criteria for inflammatory bowel disease were in accordance with the European Crohn's and Colitis Organisation (ECCO) guidelines; 3.Patients' medical records and follow-up information were complete; 4.All received nutritional assessment tests.

Exclusion criteria

Exclusion criteria: 1.Patients who refuse to undergo nutritional testing; 2. Preparation for pregnancy, pregnancy and breastfeeding patients; 3.Presence of short bowel syndrome or severe wasting disease, e.g., tumour, hyperthyroidism; 4. Existence of cardiac and renal-related chronic disease history; 5.The patient is receiving parenteral nutrition therapy; 6.Missed visits or lack of complete clinical information.

Design outcomes

Primary

MeasureTime frame
Incidence of adverse clinical outcomes between 6 months and 1 year follow-up from nutritional diagnosis;

Secondary

MeasureTime frame
Clinical response rate at 3 months in patients with active CD in drug-induced remission;Core indicators for body composition analysis;Assessment of improvement in patients' quality of life;Drug-induced improvement in remission of active anal fistulae;Endoscopic remission rates in patients with active CD 3 months after drug-induced remission;

Countries

China

Contacts

Public ContactXiaolei Wang

Shanghai Tenth People's Hospital

xlwang2006@163.com+86 13817267967

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026